Clinical characteristics | N° (%) | DSU (%) | BMTU (%) | |
---|---|---|---|---|
Total biopsy | 68 (100) | 12 (17.6) | 56 (82.3) | |
Number of biopsy per patient | 1 | 17 (37,7) | 3 (17.6) | 14 (82.3) |
2 | 17 (37,7) | 3 (17.6) | 14 (82.3) | |
≥3 | 11 (24,4) | 1 (9.1) | 10 (90.9) | |
Histological diagnosis | Drug Hepatotoxicity | 2 (3,9) | 1 (50.0) | 1 (50.0) |
AIH | 1 (1,4) | - | 1 (100) | |
GVHD | 24 (35,2) | 4 (16,7) | 20 (83.3) | |
GVHD + IO | 19 (27,9) | 3 | 16 | |
GVHD + IO + Infection | 1 (1,4) | - | 1 (100) | |
GVHD + IO + MD | 2 (2,9) | - | 2 (100) | |
Infection | 4 (5,8) | 1 (25.0) | 3 (75.0) | |
IO + Drug toxicity | 4 (5,8) | 1 (25.0) | 3 (75.0) | |
IO + Infection | 1 (1,4) | 1 (100) | - | |
IO + MD | 1 (1,4) | - | 1 (100) | |
Iron overload | 6 (8,8) | 1 (16.7) | 5 (83.3) | |
Metabolic Disorders | 2 (2,9) | 0 | 2 (100) | |
Normal | 1 (1,4) | 0 | 1 (100) | |
Changes in clinical management | No | 32 (47,1) | 3 (9.4) | 29 (90.6) |
Yes | 36 (52,9) | 9 (25.0) | 27 (75.0) | |
Outcome | Improved | 33 (48,5) | 6 (18.2) | 27 (81.8) |
Recovered | 13 (19,1) | 2 (15.4) | 11 (84.6) | |
Not changed | 19 (27,9) | 2 (10.5) | 17 (89.5) | |
Worsened | 1 (1,4) | 1 (100) | 0 | |
Death | 2 (2,9) | 1 (50.0) | 1 (50.0) |